Healthcare - Biotechnology - NASDAQ - US
$ 0.3353
0.119 %
$ 24.3 M
Market Cap
-0.45
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
76.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
IN8bio, Inc.
INAB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart INAB
EBIT FORECAST
EBIT Forecast Chart INAB
NET INCOME FORECAST
Net Income Chart INAB